The Celia Scott Weatherhead School of Public Health and Tropical Medicine at Tulane University appointed Shalini Kulasingam as the founding director of the school’s newly established Center for Cancer Prevention and Control, effective July 1.
NRG Oncology, an NCI National Clinical Trials Network group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced new chair and vice chair appointments to the NRG NCI Community Oncology Research Program Cancer Prevention & Control Committee.
NYU Langone announced on May 21 the creation of the Mignone Women’s Health Collaborative, building upon the system’s health care services for women and deepening coordination between specialists who work together to treat women at every stage of life.
Barbara Summers, a pioneering nurse leader, mentor and champion of patient-centered care, died May 6, in Richmond, Virginia, surrounded by her family.
On May 21, the governing body of the Cancer Prevention and Research Institute of Texas approved 61 grants totaling more than $93 million. The grants support cancer research and prevention projects across the entire spectrum of CPRIT’s mission, including CPRIT Scholar recruitment grants, a wide array of evidence-based prevention programs, and funding for early-stage companies developing promising new treatments for cancer.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center announced a $150 million gift from Kinder Foundation.
UT Southwestern Medical Center broke ground May 12 on a $177 million radiation oncology campus that will provide advanced therapies for patients of Fort Worth, TX, the nation’s 12th-largest city.
City of Hope opened its largest outpatient facility among its network of 38 U.S. locations—Hope Plaza.
RWJBarnabas Health and Rutgers Cancer Institute, the state’s only NCI-designated Comprehensive Cancer Center, have opened New Jersey’s first and only freestanding, fully comprehensive cancer hospital (The Cancer Letter, April 25, 2025).
Richard M. Goldberg, an expert in gastrointestinal cancer treatment and research, has joined Agenus as chief development officer.
